A research team from the School of Chinese Medicine at
Read moreThe first drug in Hong Kong to be granted orphan drug designation by the US FDA
Home »
FDA Grants Orphan Drug Designation to Amplyx Pharmaceuticals for APX001 for Treatment of Cryptococcosis
SAN DIEGO – February 11, 2019 – Amplyx Pharmaceuticals, a
Read moreAxsome Therapeutics Receives FDA Orphan Drug Designation for AXS-12 for the Treatment of Narcolepsy
NEW YORK, Oct. 17, 2018 (GLOBE NEWSWIRE) — Axsome Therapeutics,
Read moreAronora’s New Blood Clot Treatment proCase Receives FDA Fast Track Designation
PORTLAND, Ore., Sept. 26, 2018 /PRNewswire/ — Aronora Inc., a
Read moreHTX-011 for Postoperative Pain Management Receives Breakthrough Therapy Designation from FDA
SAN DIEGO–(BUSINESS WIRE)–Jun. 21, 2018– Heron Therapeutics, Inc. (NASDAQ: HRTX),
Read more